A magnetic T7 peptide&AS1411 aptamer-modified microemulsion for triple glioma-targeted delivery of shikonin and docetaxel.
暂无分享,去创建一个
[1] Chuanlu Jiang,et al. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma , 2020, Theranostics.
[2] E. Vázquez,et al. Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells. , 2019, ACS applied materials & interfaces.
[3] Sanyog Jain,et al. Exploring the potential of novel pH sensitive lipoplexes for tumor targeted gene delivery with reduced toxicity. , 2019, International journal of pharmaceutics.
[4] Lukui Chen,et al. AS1411 aptamer/hyaluronic acid-bifunctionalized microemulsion co-loading shikonin and docetaxel for enhanced anti-glioma therapy. , 2019, Journal of pharmaceutical sciences.
[5] B. Verrier,et al. AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[6] A. Mahajan,et al. Carbon ion radiotherapy in the treatment of gliomas: a review , 2019, Journal of Neuro-Oncology.
[7] C. Shih,et al. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. , 2019, Pharmacological research.
[8] K. Bunyaratavej,et al. Catheter guided cerebral glioma resection combined with awake craniotomy: its usefulness and surgical outcome , 2019, British journal of neurosurgery.
[9] P. Lowenstein,et al. High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme. , 2019, ACS nano.
[10] Mengfei Guo,et al. Non-triggered sequential-release liposomes enhance anti-breast cancer efficacy of STS and celastrol-based microemulsion. , 2018, Biomaterials science.
[11] Swastik Pradhan,et al. Role of Mono- and Divalent Surface Cations on the Structure and Adsorption Behavior of Water on Mica Surface. , 2018, Langmuir : the ACS journal of surfaces and colloids.
[12] Wenjun Jiang,et al. Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer , 2018, International journal of nanomedicine.
[13] Jing Qin,et al. Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery. , 2018, ACS applied materials & interfaces.
[14] N. Butowski,et al. Primary brain tumours in adults , 2018, The Lancet.
[15] Yang Yang,et al. Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles , 2018, Drug delivery.
[16] Yulun Huang,et al. Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy , 2017, Oncotarget.
[17] Yinsheng Chen,et al. Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging , 2017, Neuro-oncology.
[18] M. Schaffer,et al. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review. , 2017, Current medicinal chemistry.
[19] Ran Mo,et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. , 2017, Nature nanotechnology.
[20] G. Reifenberger,et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.
[21] Nathalie Y. R. Agar,et al. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents , 2017, Nature Communications.
[22] D. Wion. Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia , 2017, Journal of Neuro-Oncology.
[23] C. Shi,et al. Nucleolin-targeted selenium nanocomposites with enhanced theranostic efficacy to antagonize glioblastoma. , 2017, Journal of materials chemistry. B.
[24] Zhixing Zheng,et al. T7 Peptide-Functionalized PEG-PLGA Micelles Loaded with Carmustine for Targeting Therapy of Glioma. , 2016, ACS applied materials & interfaces.
[25] Boguang Yang,et al. Zwitterionic-Modified Starch-Based Stealth Micelles for Prolonging Circulation Time and Reducing Macrophage Response. , 2016, ACS applied materials & interfaces.
[26] S. May,et al. Emergence of a Stern Layer from the Incorporation of Hydration Interactions into the Gouy-Chapman Model of the Electrical Double Layer. , 2015, Langmuir : the ACS journal of surfaces and colloids.
[27] Ding Qu,et al. Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation , 2013, International journal of nanomedicine.
[28] Q. Lan,et al. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. , 2013, ACS applied materials & interfaces.
[29] N. Zhang,et al. In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery. , 2013, Carbohydrate polymers.
[30] Chen Jiang,et al. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. , 2011, Biomaterials.
[31] Morteza Mahmoudi,et al. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. , 2011, Nanoscale.
[32] Narendra Singh,et al. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. , 2009, Cancer letters.
[33] James Inglese,et al. Ligand-receptor binding measured by laser-scanning imaging. , 1999, Proceedings of the National Academy of Sciences of the United States of America.